- Report ID : MD1438 |
- Pages : 240 |
- Tables : 85 |
- Formats :
By Application (Muscle Spasms, Anorexia, Seizures, Nausea, Pain Management [Neuropathic Pain, Cancer Pain]), By Route of Administration (Oral, Topical, Inhalation), By Distribution Channel (Online, Dispensaries), Industry Outlook Report, Regional Analysis (U.S., Canada, Germany, U.K., France, Italy, Spain, Russia, Poland, Austria, Luxembourg, China, India, Vietnam, Japan, Tajikistan, Indonesia, Thailand, Malaysia, Australia, New Zealand, Colombia, Argentina, Bolivia, Peru, Saudi Arabia, Ethiopia, Botswana, Morocco, Nigeria)
Medical Marijuana Market size was estimated at $17,045.6 Million in 2019 and is expected to reach $58,283.6 Million by 2027, growing at a CAGR of 19.2% during the forecast period of 2020 to 2027.
Medical Marijuana is made from extracts of the Marijuana plant for medical applications. The strong, positive R&D in the field of marijuana is likely to accelerate sales. This is especially true in certain forms of epilepsy. Consumer acceptance in various countries are likely to legalize its use. However, the challenges of some side-effects of its use will need to be addressed. Additionally, since Medical Marijuana is technically the same extract as Recreational Marijuana, checks and balances in its trade will need to be developed and implemented for a successful endeavor.
Analysis by Application
According to the application, the segments are Muscle Spasms, Anorexia, Seizures, Nausea, and Pain Management. Pain Management is further classified into Neuropathic Pain and Cancer Pain. The Medical Marijuana market report notes that the lion’s share of the market is ruled by the application in Pain Management. Marijuana has very little side-effects and is thus being rapidly recommended by doctors to their patients, especially in cases of chronic pain. The Medical Marijuana market research proves that nearly 20% of American adults suffer from this ailment.
Analysis by Route of Administration
The three segments under Route of Administration are Oral, Topical, and Inhalation. The Medical Marijuana market share is dominated by the Inhalation route of administration, which holds nearly a 75% share. This skewed preference is because an important element of medical cannabis is best administered via the lungs.
Analysis by Distribution Channel
According to the distribution channel, the two main segments are Online and Dispensaries. The Medical Marijuana market size is likely to grow in the Dispensaries segment as patients prefer to make medical purchases from authorized brick and mortar stores over the Online option. The Medical Marijuana market estimation for the latter is very bullish owing to the gradual legalization of medical cannabis by various governments.
Analysis by Region
The Medical Marijuana market forecast is the brightest in the European region. Germany’s recent legalization of Medical Cannabis has set the ball rolling for other European nations to embrace the product as well. This is expected to create an excellent Medical Marijuana Price trend and will foster business growth.
The North American market is also undertaking dedicated R&D in this field and the interim results are painting a very optimistic picture for the companies in this fray. Awareness initiatives by various states will further augment product adoption.
Analysis by Eminent Enterprises
A few leading Medical Marijuana companies are Aphria, Inc., Aurora Cannabis, Inc., Canopy Growth Corporation, and mCig, Inc. Mergers and strategic collaborations will pave the way for the success of this industry in the forecasted period. An instance of a Backward integration took place recently when a large company bought one of its vendors to gain a competitive advantage in the extraction of a raw material. On the other hand, an example of Forward integration became the talk of the town as a Manufacturer acquired a company that dealt with the logistics and the distribution network of Medical Cannabis in Europe. This will create commercial synergy for the acquirer.
COVERAGE HIGHLIGHTS
• Market Revenue Estimation and Forecast (2019 – 2026)
• Market Production Estimation and Forecast (2019 – 2026)
• Market Sales/Consumption Volume Estimation and Forecast (2019 – 2026)
• Breakdown of Revenue by Segments (2019 – 2026)
• Breakdown of Production by Segments (2019 – 2026)
• Breakdown of Sales Volume by Segments (2019 – 2026)
• Gross Margin and Profitability Analysis of Companies
• Business Trend and Expansion Analysis
• Import and Export Analysis
• Regional Analysis and Market Data Breakdown
MARKET SEGMENTATION
By Application Outlook ($Revenue and Unit Sales, 2019-2026)
• Muscle Spasms
• Anorexia
• Seizures
• Nausea
• Pain Management
o Neuropathic Pain
o Cancer Pain
By Route of Administration Outlook ($Revenue and Unit Sales, 2019-2026)
• Oral
• Topical
• Inhalation
By Distribution Channel Outlook ($Revenue and Unit Sales, 2019-2026)
• Online
• Dispensaries
By Regional Outlook ($Revenue and Unit Sales, 2019-2026)
• North America
o U.S.
o Canada
• Europe
o Germany
o U.K.
o France
o Italy
o Spain
o Russia
o Poland
o Austria
o Luxembourg
• Asia-Pacific
o China
o India
o Vietnam
o Japan
o Tajikistan
o Indonesia
o Thailand
o Malaysia
o Australia
o New Zealand
• Latin America
o Colombia
o Argentina
o Bolivia
o Peru
• Middle East & Africa
o Saudi Arabia
o Ethiopia
o Botswana
o Morocco
o Nigeria
Eminent Enterprises
• ABcannMedicinals, Inc.
• Aphria, Inc.
• Aurora Cannabis, Inc.
• Cannabis Sativa Inc.
• Canopy Growth Corporation
• Emerald Health Therapeutics Inc.
• Green Relief Inc.
• GW Pharmaceuticals
• Insys Therapeutics, Inc.
• Maricann Group, Inc.
• mCig, Inc.
• Medical Marijuana, Inc.
• The Cronos Group Inc.
• Tilray
• United Cannabis
• The Supreme Cannabis Company
CHAPTER 1: INTRODUCTION
1.1. RESEARCH METHODOLOGY
1.1.1. Desk Research
1.1.2. Data Synthesis
1.1.3. Data Validation & Market Feedback
1.1.4. Data Sources
CHAPTER 2: EXECUTIVE SUMMARY
2.1. GLOBAL MARKET OUTLOOK
2.2. CORE INSIGHTS –DELIVERY MODEL
2.3. CORE INSIGHTS – MEDICAL MARIJUANA
2.4. CORE INSIGHTS – SERVICE PROVIDER
2.5. CORE INSIGHTS – GEOGRAPHY
CHAPTER 3: MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FORCES SHAPING THE INDUSTRY
3.2.1. Bargaining Power of Suppliers
3.2.2. Bargaining Power of Buyers
3.2.3. Threat of Substitutes
3.2.4. Threat of New Entrants
3.3. MARKET DYNAMICS
3.3.1. Drivers
3.3.1.1. Supply-side Drivers
3.3.1.2. Demand-side Drivers
3.3.2. Restraints
3.3.3. Opportunities
3.4. INDUSTRY - ANALYSIS
3.4.1. Political Market
3.4.2. Environmental Market
3.4.3. Social Market
3.4.4. Technology Market
CHAPTER 4: MARKET BACKGROUND
4.1. Industry Value Chain Analysis
4.1.1. Upstream Participants
4.1.2. Downstream participants
4.2. Pricing Analysis and Forecast, 2019-2026
4.2.1. By Type
4.2.2. By Region
CHAPTER 5: MEDICAL MARIJUANA MARKET, BY APPLICATION OUTLOOK
5.1. Overview
5.1.1. Market Revenue (US$ Million) and Forecast, 2019-2026
5.2. Muscle Spasms
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Revenue (US$ Million) and Forecast, By Region
5.3. Anorexia
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Revenue (US$ Million) and Forecast, By Region
5.4. Seizures
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Revenue (US$ Million) and Forecast, By Region
5.5. Nausea
5.5.1. Key Market Trends, Growth Factors and Opportunities
5.5.2. Market Revenue (US$ Million) and Forecast, By Region
5.6. Pain Management
5.6.1. Key Market Trends, Growth Factors and Opportunities
5.6.2. Market Revenue (US$ Million) and Forecast, By Region
5.7. Neuropathic Pain
5.7.1. Key Market Trends, Growth Factors and Opportunities
5.7.2. Market Revenue (US$ Million) and Forecast, By Region
5.8. Cancer Pain
5.8.1. Key Market Trends, Growth Factors and Opportunities
5.8.2. Market Revenue (US$ Million) and Forecast, By Region
CHAPTER 6: MEDICAL MARIJUANA AVIONICS MARKET BY ROUTE OF ADMINISTRATION OUTLOOK
6.1. Overview
6.1.1. Market Revenue (US$ Million) and Forecast, 2019-2026
6.2. Oral
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Revenue (US$ Million) and Forecast, By Region
6.3. Topical
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Revenue (US$ Million) and Forecast, By Region
6.4. Inhalation
6.4.1. Key Market Trends, Growth Factors and Opportunities
6.4.2. Market Revenue (US$ Million) and Forecast, By Region
CHAPTER 7: MEDICAL MARIJUANA MARKET BY DISTRIBUTION CHANNEL OUTLOOK
7.1. Overview
7.1.1. Market Revenue (US$ Million) and Forecast, 2019-2026
7.2. Online
7.2.1. Key Market Trends, Growth Factors and Opportunities
7.2.2. Market Revenue (US$ Million) and Forecast, By Region
7.3. Dispensaries
7.3.1. Key Market Trends, Growth Factors and Opportunities
CHAPTER 8: MEDICAL MARIJUANA MARKET, BY GEOGRAPHY
8.1. Overview
8.2. North America
8.2.1. Key Market Trends, Growth Factors and Opportunities
8.2.2. Market Revenue and Forecast, By Delivery Model
8.2.3. Market Revenue and Forecast, By Agriculture Type
8.2.4. Market Revenue and Forecast, By Service Provider
8.2.5. Market Revenue and Forecast, By Country
8.2.6. U.S.
8.2.6.1. Market Revenue and Forecast
8.2.7. Canada
8.2.7.1. Market Revenue and Forecast
8.2.8. Mexico
8.2.8.1. Market Revenue and Forecast
8.3. Europe
8.3.1. Market Revenue and Forecast, By Delivery Model
8.3.2. Market Revenue and Forecast, By Agriculture Type
8.3.3. Market Revenue and Forecast, By Service Provider
8.3.4. Market Revenue and Forecast, By Country
8.3.5. Germany
8.3.5.1. Market Revenue and Forecast
8.3.6. UK
8.3.6.1. Market Revenue and Forecast
8.3.7. France
8.3.7.1. Market Revenue and Forecast
8.3.8. Italy
8.3.8.1. Market Revenue and Forecast
8.3.9. Spain
8.3.9.1. Market Revenue and Forecast
8.3.10. Poland
8.3.10.1. Market Revenue and Forecast
8.3.11. Austrai
8.3.11.1. Market Revenue and Forecast
8.3.12. Luxembourg
8.3.12.1. Market Revenue and Forecast
8.3.13. Rest of Europe
8.3.13.1. Market Revenue and Forecast
8.4. Asia-Pacific
8.4.1. Market Revenue and Forecast, By Delivery Model
8.4.2. Market Revenue and Forecast, By Agriculture Type
8.4.3. Market Revenue and Forecast, By Service Provider
8.4.4. Market Revenue and Forecast, By Country
8.4.5. China
8.4.5.1. Market Revenue and Forecast
8.4.6. India
8.4.6.1. Market Revenue and Forecast
8.4.7. Japan
8.4.7.1. Market Revenue and Forecast
8.4.8. South Korea
8.4.8.1. Market Revenue and Forecast
8.4.9. Rest of APAC
8.4.9.1. Market Revenue and Forecast
8.5. REST OF THE WORLD
8.5.1. Market Revenue and Forecast, By Delivery Model
8.5.2. Market Revenue and Forecast, By Agriculture Type
8.5.3. Market Revenue and Forecast, By Service Provider
8.5.4. Market Revenue and Forecast, By Country
8.5.5. Latin America
8.5.5.1. Market Revenue and Forecast
8.5.6. Middle East
8.5.6.1. Market Revenue and Forecast
8.5.7. Africa
8.5.7.1. Market Revenue and Forecast
CHAPTER 9: COMPETITIVE MARKET
9.1. MEDICAL MARIJUANA MARKET, 2019
CHAPTER 10: COMPANY PROFILES
10.1. Airbus S.A.S
10.1.1. Company Overview
10.1.2. Financial Performance
10.1.3. SWOT Analysis
10.2. Aviation Industry Corporation of China Ltd. (AVIC)
10.2.1. Company Overview
10.2.2. Financial Performance
10.2.3. SWOT Analysis
10.3. Astronics Corporation
10.3.1. Company Overview
10.3.2. Financial Performance
10.3.3. SWOT Analysis
10.4. Boeing
10.4.1. Company Overview
10.4.2. Financial Performance
10.4.3. SWOT Analysis
10.5. Ball Corporation
10.5.1. Company Overview
10.5.2. Financial Performance
10.5.3. SWOT Analysis
10.6. BAE Systems
10.6.1. Company Overview
10.6.2. Financial Performance
10.6.3. SWOT Analysis
10.7. Cobham plc
10.7.1. Company Overview
10.7.2. Financial Performance
10.7.3. SWOT Analysis
10.8. Curtiss Wright
10.8.1. Company Overview
10.8.2. Financial Performance
10.8.3. SWOT Analysis
10.9. Elbit System
10.9.1. Company Overview
10.9.2. Financial Performance
10.9.3. SWOT Analysis
10.10. Gramin Ltd
10.10.1. Company Overview
10.10.2. Financial Performance
10.10.3. SWOT Analysis
10.11. GE Aviation
10.11.1. Company Overview
10.11.2. Financial Performance
10.11.3. SWOT Analysis
10.12. Harris Corporation
10.12.1. Company Overview
10.12.2. Financial Performance
10.12.3. SWOT Analysis
10.13. Honeywell International Inc.
10.13.1. Company Overview
10.13.2. Financial Performance
10.13.3. SWOT Analysis
10.14. Lockheed Martin Corporation
10.14.1. Company Overview
10.14.2. Financial Performance
10.14.3. SWOT Analysis
10.15. L3 Harris Corporation
10.15.1. Company Overview
10.15.2. Financial Performance
10.15.3. SWOT Analysis
10.16. Meggitt PLC
10.16.1. Company Overview
10.16.2. Financial Performance
10.16.3. SWOT Analysis
10.17. Northrop Grumman Corporation
10.17.1. Company Overview
10.17.2. Financial Performance
10.17.3. SWOT Analysis
10.18. Nucon Aerospace
10.18.1. Company Overview
10.18.2. Financial Performance
10.18.3. SWOT Analysis
10.19. Panasonic Corporation
10.19.1. Company Overview
10.19.2. Financial Performance
10.19.3. SWOT Analysis
10.20. Rolls Royce
10.20.1. Company Overview
10.20.2. Financial Performance
10.20.3. SWOT Analysis
10.21. Raytheon Company
10.21.1. Company Overview
10.21.2. Financial Performance
10.21.3. SWOT Analysis
10.22. Saab AB
10.22.1. Company Overview
10.22.2. Financial Performance
10.22.3. SWOT Analysis
10.23. Safran
10.23.1. Company Overview
10.23.2. Financial Performance
10.23.3. SWOT Analysis
10.24. Thales Group
10.24.1. Company Overview
10.24.2. Financial Performance
10.24.3. SWOT Analysis
10.25. Teledyne Technologies Inc.
10.25.1. Company Overview
10.25.2. Financial Performance
10.25.3. SWOT Analysis
10.26. Transdigm Group Inc.
10.26.1. Company Overview
10.26.2. Financial Performance
10.26.3. SWOT Analysis
20% Free Customization ON ALL PURCHASE
*Terms & Conditions Apply
Please fill in the form below to Request for free Sample Report
Office Hours Mon - Sat 10:00 - 16:00
Send Us Mail sales@marketdecipher.com
Market Decipher is a market research and consultancy firm involved in provision of market reports to organisations of varied sizes; small, large and medium.
© 2018 Market Decipher. All Rights Reserved
